Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SMOFLIPID 20%
- Lipid Emulsion Infusion and COVID-19 Patients
- Lipid Emulsion in Cardiac Valve Replacement Surgery
- Diagnostic Role of the "White Test" With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial)
- Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature Infants
- Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age
- LIPIDS-P Trial Phase I/II
- Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates
- The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis
- Crossover Study on the Effect of Omegaven in Combination With Different Lipid Emulsions in Home Parenteral Nutrition
- SMOFLipid in Patients Who Are Intralipid Intolerant
- A Fatty Acids Study in Preventing Retinopathy of Prematurity
- SMOFlipid to Lessen the Severity of Neonatal Cholestasis
- Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants
- Pilot Study: Hepatoprotective Role of SMOFlipid® Used in Short-term Parenteral Nutrition in an Onco-Hematology Pediatric Population
- SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
- Preventing Cholestasis Using SMOFLipid®
- Efficacy and Safety Comparison Between SMOFlipid and Lipovenoes MCT
- Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?
- Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition
Clinical trials list
click for details